Management of patients with chronic lymphocytic leukemia at high risk of relapse on ibrutinib therapy.
about
Management of patients with chronic lymphocytic leukemia at high risk of relapse on ibrutinib therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Management of patients with ch ...... relapse on ibrutinib therapy.
@en
Management of patients with ch ...... relapse on ibrutinib therapy.
@nl
type
label
Management of patients with ch ...... relapse on ibrutinib therapy.
@en
Management of patients with ch ...... relapse on ibrutinib therapy.
@nl
prefLabel
Management of patients with ch ...... relapse on ibrutinib therapy.
@en
Management of patients with ch ...... relapse on ibrutinib therapy.
@nl
P2860
P1433
P1476
Management of patients with ch ...... f relapse on ibrutinib therapy
@en
P2093
Sameer A Parikh
P2860
P304
P356
10.1080/10428194.2017.1397665
P50
P577
2017-11-08T00:00:00Z